Cinryze (HUMAN C1-ESTERASE INHIBITOR)

**Product type:** Plasma Derivative

**Active ingredient:** HUMAN C1-ESTERASE INHIBITOR

**Strength:** 500 [iU]/5mL

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** Takeda Pharmaceuticals America, Inc.

**Marketing category:** BLA (BLA125267)

**Pharmacologic class:** Decreased Vascular Permeability [PE], Human C1 Esterase Inhibitor [EPC], Kallikrein Inhibitors [MoA]